Stress-induced decrease of 3-methoxytyramine in the nucleus accumbens of the mouse is prevented by naltrexone pretreatment

Simona Cabib, Alberto Oliverio, Stefano Puglisi-Allegra

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Pretreatment with naltrexone (2.5 and 5 mg/kg) prevented the decrease of 3-methoxytyramine (3-MT)/dopamine (DA) ratio induced by 2 h immobilization stress in the nucleus accumbens (NAS) of the mouse while it did not affect the stress-induced decrease of 3-MT/DA ratio in caudatus putamen (CP). Naltrexone also produced a slight antagonism of homovanillic acid (HVA)/DA ratio increase produced by stress in the frontal cortex (FC). These results point to an involvement of endogenous opioids in the effects of stress on DA metabolism in the mesolimbic system of the mouse.

Original languageEnglish
Pages (from-to)1031-1037
Number of pages7
JournalLife Sciences
Volume45
Issue number12
DOIs
Publication statusPublished - 1989

Fingerprint

Naltrexone
Nucleus Accumbens
Dopamine
Homovanillic Acid
Caudate Nucleus
Putamen
Frontal Lobe
Metabolism
Immobilization
Opioid Analgesics
3-methoxytyramine

ASJC Scopus subject areas

  • Pharmacology

Cite this

Stress-induced decrease of 3-methoxytyramine in the nucleus accumbens of the mouse is prevented by naltrexone pretreatment. / Cabib, Simona; Oliverio, Alberto; Puglisi-Allegra, Stefano.

In: Life Sciences, Vol. 45, No. 12, 1989, p. 1031-1037.

Research output: Contribution to journalArticle

@article{fbd4a5569f9d4b749cced7a6e18943d4,
title = "Stress-induced decrease of 3-methoxytyramine in the nucleus accumbens of the mouse is prevented by naltrexone pretreatment",
abstract = "Pretreatment with naltrexone (2.5 and 5 mg/kg) prevented the decrease of 3-methoxytyramine (3-MT)/dopamine (DA) ratio induced by 2 h immobilization stress in the nucleus accumbens (NAS) of the mouse while it did not affect the stress-induced decrease of 3-MT/DA ratio in caudatus putamen (CP). Naltrexone also produced a slight antagonism of homovanillic acid (HVA)/DA ratio increase produced by stress in the frontal cortex (FC). These results point to an involvement of endogenous opioids in the effects of stress on DA metabolism in the mesolimbic system of the mouse.",
author = "Simona Cabib and Alberto Oliverio and Stefano Puglisi-Allegra",
year = "1989",
doi = "10.1016/0024-3205(89)90159-8",
language = "English",
volume = "45",
pages = "1031--1037",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "12",

}

TY - JOUR

T1 - Stress-induced decrease of 3-methoxytyramine in the nucleus accumbens of the mouse is prevented by naltrexone pretreatment

AU - Cabib, Simona

AU - Oliverio, Alberto

AU - Puglisi-Allegra, Stefano

PY - 1989

Y1 - 1989

N2 - Pretreatment with naltrexone (2.5 and 5 mg/kg) prevented the decrease of 3-methoxytyramine (3-MT)/dopamine (DA) ratio induced by 2 h immobilization stress in the nucleus accumbens (NAS) of the mouse while it did not affect the stress-induced decrease of 3-MT/DA ratio in caudatus putamen (CP). Naltrexone also produced a slight antagonism of homovanillic acid (HVA)/DA ratio increase produced by stress in the frontal cortex (FC). These results point to an involvement of endogenous opioids in the effects of stress on DA metabolism in the mesolimbic system of the mouse.

AB - Pretreatment with naltrexone (2.5 and 5 mg/kg) prevented the decrease of 3-methoxytyramine (3-MT)/dopamine (DA) ratio induced by 2 h immobilization stress in the nucleus accumbens (NAS) of the mouse while it did not affect the stress-induced decrease of 3-MT/DA ratio in caudatus putamen (CP). Naltrexone also produced a slight antagonism of homovanillic acid (HVA)/DA ratio increase produced by stress in the frontal cortex (FC). These results point to an involvement of endogenous opioids in the effects of stress on DA metabolism in the mesolimbic system of the mouse.

UR - http://www.scopus.com/inward/record.url?scp=0024446943&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024446943&partnerID=8YFLogxK

U2 - 10.1016/0024-3205(89)90159-8

DO - 10.1016/0024-3205(89)90159-8

M3 - Article

C2 - 2796595

AN - SCOPUS:0024446943

VL - 45

SP - 1031

EP - 1037

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 12

ER -